Literature DB >> 11962743

Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic (NOD) mice during the early neonatal period.

S Charré1, J G M Rosmalen, C Pelegri, V Alves, P J M Leenen, H A Drexhage, F Homo-Delarche.   

Abstract

Dendritic cell (DC), macrophage (Mphi) and lymphocyte infiltrations have been observed in normal human perinatal pancreata, but have never been investigated so early in control mice. In type 1 diabetes-prone NOD mice, these cells are thought to infiltrate first the periphery of the islets of Langerhans around weaning before further islet infiltration and beta-cell destruction. We quantified, during the first month of life, the numbers of DC (characterized by CD11c positivity and dendritic morphology), histiocyte-like Mphi (characterized by ER-MP23 positivity) and Mphi with scavenging potential (characterized by BM8 positivity) in C57BL/6, DBA/2 and BALB/c control, and NOD and lymphocyte-deficient NODscid mouse pancreata. First, CD11c+ DC were present at low densities from birth onwards in control pancreata, while densities were higher in NOD and NODscid. Second, high numbers of BM8+ and ER-MP23+ Mphi were observed at birth in all strains investigated. After birth, particularly BM8+ cells disappeared progressively in control strains, but not in NOD and NODscid. Third, NOD mice also had more ER-MP23+ Mphi at birth compared to controls. Finally, DC and Mphi localizations were similar in all strains, i.e., mostly as dispersed cells in perivascular, periductular, peri-islet areas and interlobular septa. The most remarkable finding was that particularly BM8+ Mphi, were seen at sites of islet neogenesis and predominantly at the duct-islet interface. Our data showed that different types of APC were present in the pancreas during postnatal development in various control mouse strains and some differences were observed in NOD and NODscid mice from birth onwards.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11962743     DOI: 10.14670/HH-17.393

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  19 in total

1.  Role of endogenous IL-6 in the neonatal expansion and functionality of Wistar rat pancreatic alpha cells.

Authors:  E Fernández-Millán; J de Toro-Martín; E Lizárraga-Mollinedo; F Escrivá; C Álvarez
Journal:  Diabetologia       Date:  2013-02-23       Impact factor: 10.122

2.  Glucose homeostasis in pre-diabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation.

Authors:  Josiane Coulaud; Sylvie Durant; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2010-05-10

3.  Exaggerated Increases in Microglia Proliferation, Brain Inflammatory Response and Sickness Behaviour upon Lipopolysaccharide Stimulation in Non-Obese Diabetic Mice.

Authors:  Barry McGuiness; Sinead M Gibney; Wouter Beumer; Marjan A Versnel; Inge Sillaber; Andrew Harkin; Hemmo A Drexhage
Journal:  Neuroimmunomodulation       Date:  2016-08-17       Impact factor: 2.492

4.  Growth hormone prevents the development of autoimmune diabetes.

Authors:  Ricardo Villares; Dimitri Kakabadse; Yasmina Juarranz; Rosa P Gomariz; Carlos Martínez-A; Mario Mellado
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 5.  High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

Authors:  Valeria Chirico; Antonio Lacquaniti; Vincenzo Salpietro; Caterina Munafò; Maria Pia Calabrò; Michele Buemi; Teresa Arrigo; Carmelo Salpietro
Journal:  Eur J Pediatr       Date:  2014-05-09       Impact factor: 3.183

6.  Increased transcriptional preproinsulin II beta-cell activity in neonatal nonobese diabetic mice: in situ hybridization analysis.

Authors:  Marc Throsby; Josiane Coulaud; Sylvie Durant; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2005-08-10

7.  Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.

Authors:  C Gysemans; K Stoffels; A Giulietti; L Overbergh; M Waer; M Lannoo; U Feige; C Mathieu
Journal:  Diabetologia       Date:  2003-07-17       Impact factor: 10.122

Review 8.  Immunomodulation of autoimmune diabetes by dendritic cells.

Authors:  Klaus Pechhold; Kerstin Koczwara
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

9.  Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.

Authors:  Marcia McDuffie; Nelly A Maybee; Susanna R Keller; Brian K Stevens; James C Garmey; Margaret A Morris; Elizabeth Kropf; Claudia Rival; Kaiwen Ma; Jeffrey D Carter; Sarah A Tersey; Craig S Nunemaker; Jerry L Nadler
Journal:  Diabetes       Date:  2007-10-16       Impact factor: 9.461

Review 10.  HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes.

Authors:  Shu Zhang; Jixin Zhong; Ping Yang; Feili Gong; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2009-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.